BRPI0514939A - método para matar ou inativar microorganismos no tecido de mamìfero, composição antimicrobiana, e, método para descolonizar pelo menos uma porção das cavidades nasais, narinas anteriores, e/ou nasofaringe de um indivìduo, para descolonizar pelo menos uma porção da cavidade esofágica de um indivìduo, para prevenir e/ou tratar uma aflição causada, ou agravada por, um organismo microbiano na pele e/ou membrana mucosal, para fornecer eficácia antimicrobiana residual em uma superfìcie, para prevenir e/ou de tratar um indivìduo para uma aflição respiratória causada por uma infecção microbiana, para tratar uma infecção de ouvido médio em um indivìduo, para tratar sinusite crÈnica em um indivìduo, para tratar impetigo na pele de um indivìduo, para tratar e/ou prevenir uma infecção no tecido de mamìfero, para tratar e/ou prevenir uma infecção na pele, no tecido mucosal, e/ou na ferida de um indivìduo, para fornecer eficácia antimicrobiana residual na pele, no tecido mucosal, e/ou em uma ferida de um indivìduo e para fazer uma composição antimicrobiana - Google Patents

método para matar ou inativar microorganismos no tecido de mamìfero, composição antimicrobiana, e, método para descolonizar pelo menos uma porção das cavidades nasais, narinas anteriores, e/ou nasofaringe de um indivìduo, para descolonizar pelo menos uma porção da cavidade esofágica de um indivìduo, para prevenir e/ou tratar uma aflição causada, ou agravada por, um organismo microbiano na pele e/ou membrana mucosal, para fornecer eficácia antimicrobiana residual em uma superfìcie, para prevenir e/ou de tratar um indivìduo para uma aflição respiratória causada por uma infecção microbiana, para tratar uma infecção de ouvido médio em um indivìduo, para tratar sinusite crÈnica em um indivìduo, para tratar impetigo na pele de um indivìduo, para tratar e/ou prevenir uma infecção no tecido de mamìfero, para tratar e/ou prevenir uma infecção na pele, no tecido mucosal, e/ou na ferida de um indivìduo, para fornecer eficácia antimicrobiana residual na pele, no tecido mucosal, e/ou em uma ferida de um indivìduo e para fazer uma composição antimicrobiana

Info

Publication number
BRPI0514939A
BRPI0514939A BRPI0514939-8A BRPI0514939A BRPI0514939A BR PI0514939 A BRPI0514939 A BR PI0514939A BR PI0514939 A BRPI0514939 A BR PI0514939A BR PI0514939 A BRPI0514939 A BR PI0514939A
Authority
BR
Brazil
Prior art keywords
individual
treat
skin
prevent
infection
Prior art date
Application number
BRPI0514939-8A
Other languages
English (en)
Inventor
Matthew T Scholz
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35996518&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0514939(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of BRPI0514939A publication Critical patent/BRPI0514939A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/12—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
    • A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
    • A01N47/44—Guanidine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D21/00—Nestable, stackable or joinable containers; Containers of variable capacity
    • B65D21/08—Containers of variable capacity
    • B65D21/086—Collapsible or telescopic containers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Mechanical Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

MéTODO PARA MATAR OU INATIVAR MICROORGANISMOS Nó TECIDO DE MAMìFERO, COMPOSIçãO ANTIMICROBIANA, E, MéTODO PARA DESCOLONIZAR PELO MENOS UMA PORçãO DAS CAVIDADES NASAIS, NARINAS ANTERIORES, E/OU NASOFARINGE DE UM INDIVìDUO, PARA DESCOLONIZAR PELO MENOS UMA PORçãO DA CAVIDADE ESOFáGICA DE UM INDIVìDUO, PARA PREVENIR E/OU TRATAR UMA AFLIçãO CAUSADA, OU AGRAVADA POR, UM ORGANISMO MICROBIANO NA PELE E/OU MEMBRANA MUCOSAL, PARA FORNECER EFICáCIA ANTIMICROBIANA RESIDUAL EM UMA SUPERFìCIE, PARA PREVENIR E/OU DE TRATAR UM INDIVìDUO PARA UMA AFLIçãO RESPIRATóRIA CAUSADA POR UMA INFECçãO MICROBIANA, PARA TRATAR UMA INFECçãO DE OUVIDO MéDIO EM UM INDIVìDUO, PARA TRATAR SINUSITE CRÈNICA EM UM INDIVìDUO, PARA TRATAR IMPETIGO NA PELE DE UM INDIVìDUO, PARA TRATAR E/OU PREVENIR UMA INFECçãO NO TECIDO DE MAMìFERO, PARA TRATAR E/OU PREVENIR UMA INFECçãO NA PELE, NO TECIDO MUCOSAL, E/OU NA FENDA DE UM INDIVìDUO, PARA FORNECER EFICáCIA ANTIMICROBIANA RESIDUAL NA PELE, NO TECIDO MUCOSAL, E/OU EM UMA FENDA DE UM INDIVìDUO E PARA FAZER UMA COMPOSIçãO ANTIMICROBIANA Composições anti-sépticas catiónicas, especialmente aquelas úteis quando aplicadas topicamente, particularmente em tecidos mucosais (isto é, membranas mucosais), incluindo um anti-séptico catiónico tais como biguanidas e bisbiguanidas tais como clorexidina e seus vários sais incluindo mas não limitados a sais de digliconato, diacetato, dimetossulfato, e dilactato; compostos de amónio quaternário poliméricos tal como poli(hexametileno-biguanida); prata e vários complexos de prata; compostos de amónio quaternário de molécula pequena tais como cloreto de benzalcónio e derivados alquil-substituídos; compostos de amónio quaternário de dialquila (C8-C18) de cadeia longa; haletos de cetil-piridínio e seus derivados; cloreto de benzetónio e seus derivados alquil-substituídos; e octenidina. As composições também podem incluir um componente melhorador, um tensoativo, um componente hidrofóbico, e/ou um componente hidrofilico. Tais composições proporcionam atividade antimicrobiana tópica eficaz e são conseqüentemente úteis no tratamento e/ou na prevenção de condições que são causadas, ou agravadas por, microorganismos (incluindo vírus).
BRPI0514939-8A 2004-09-07 2005-09-07 método para matar ou inativar microorganismos no tecido de mamìfero, composição antimicrobiana, e, método para descolonizar pelo menos uma porção das cavidades nasais, narinas anteriores, e/ou nasofaringe de um indivìduo, para descolonizar pelo menos uma porção da cavidade esofágica de um indivìduo, para prevenir e/ou tratar uma aflição causada, ou agravada por, um organismo microbiano na pele e/ou membrana mucosal, para fornecer eficácia antimicrobiana residual em uma superfìcie, para prevenir e/ou de tratar um indivìduo para uma aflição respiratória causada por uma infecção microbiana, para tratar uma infecção de ouvido médio em um indivìduo, para tratar sinusite crÈnica em um indivìduo, para tratar impetigo na pele de um indivìduo, para tratar e/ou prevenir uma infecção no tecido de mamìfero, para tratar e/ou prevenir uma infecção na pele, no tecido mucosal, e/ou na ferida de um indivìduo, para fornecer eficácia antimicrobiana residual na pele, no tecido mucosal, e/ou em uma ferida de um indivìduo e para fazer uma composição antimicrobiana BRPI0514939A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/936,135 US9028852B2 (en) 2004-09-07 2004-09-07 Cationic antiseptic compositions and methods of use
PCT/US2005/031956 WO2006029255A2 (en) 2004-09-07 2005-09-07 Cationic antiseptic compositions and methods of use

Publications (1)

Publication Number Publication Date
BRPI0514939A true BRPI0514939A (pt) 2008-07-01

Family

ID=35996518

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514939-8A BRPI0514939A (pt) 2004-09-07 2005-09-07 método para matar ou inativar microorganismos no tecido de mamìfero, composição antimicrobiana, e, método para descolonizar pelo menos uma porção das cavidades nasais, narinas anteriores, e/ou nasofaringe de um indivìduo, para descolonizar pelo menos uma porção da cavidade esofágica de um indivìduo, para prevenir e/ou tratar uma aflição causada, ou agravada por, um organismo microbiano na pele e/ou membrana mucosal, para fornecer eficácia antimicrobiana residual em uma superfìcie, para prevenir e/ou de tratar um indivìduo para uma aflição respiratória causada por uma infecção microbiana, para tratar uma infecção de ouvido médio em um indivìduo, para tratar sinusite crÈnica em um indivìduo, para tratar impetigo na pele de um indivìduo, para tratar e/ou prevenir uma infecção no tecido de mamìfero, para tratar e/ou prevenir uma infecção na pele, no tecido mucosal, e/ou na ferida de um indivìduo, para fornecer eficácia antimicrobiana residual na pele, no tecido mucosal, e/ou em uma ferida de um indivìduo e para fazer uma composição antimicrobiana

Country Status (11)

Country Link
US (3) US9028852B2 (pt)
EP (2) EP1786264B1 (pt)
JP (4) JP5154933B2 (pt)
KR (1) KR20070102479A (pt)
CN (1) CN101437394B (pt)
AU (1) AU2005282377B2 (pt)
BR (1) BRPI0514939A (pt)
CA (2) CA2579243C (pt)
MX (2) MX343725B (pt)
TW (1) TW200616609A (pt)
WO (1) WO2006029255A2 (pt)

Families Citing this family (190)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2484761C (en) 2002-05-24 2010-11-09 Angiotech International Ag Compositions and methods for coating medical implants
US8313760B2 (en) * 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
US20050032896A1 (en) * 2002-06-21 2005-02-10 Liisa Neumann Use of synthetic retinoic acid in form of 13-cis vitamin A for treatment of autism
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
CN100534334C (zh) * 2003-09-09 2009-09-02 3M创新有限公司 浓缩的抗菌组合物和方法
US7745509B2 (en) * 2003-12-05 2010-06-29 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
GB0426308D0 (en) * 2004-12-01 2004-12-29 Byotrol Llc Preservative and embalming fluids
KR20070113281A (ko) * 2005-03-10 2007-11-28 쓰리엠 이노베이티브 프로퍼티즈 컴파니 항미생물성 조성물 및 방법
US20060204558A1 (en) * 2005-03-10 2006-09-14 Kantner Steven S Antimicrobial pet wipes and methods
EP2497460A1 (en) * 2005-03-10 2012-09-12 3M Innovative Properties Co. Methods of reducing microbial contamination
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
JP2008533048A (ja) * 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 耳の感染症の治療方法
US20060246383A1 (en) * 2005-04-29 2006-11-02 Kai-Kong Iu Amphoteric stilbene composition
CA2613005C (en) * 2005-06-27 2017-01-17 Smith & Nephew Plc Antimicrobial biguanide metal complexes
WO2007000591A2 (en) * 2005-06-27 2007-01-04 Smith & Nephew, Plc Antimicrobial materials
US8343523B2 (en) * 2005-08-22 2013-01-01 Quick-Med Technologies, Inc. Disinfectant with durable activity based on alcohol-soluble quaternary ammonium polymers and copolymers
WO2007024973A1 (en) * 2005-08-22 2007-03-01 Quick-Med Technologies, Inc. Disinfectant with quaternary ammonium polymers and copolymers
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
GB0525504D0 (en) * 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
GB0601687D0 (en) * 2006-01-27 2006-03-08 Smith & Nephew Antimicrobial materials
US9629361B2 (en) 2006-02-09 2017-04-25 Gojo Industries, Inc. Composition and method for pre-surgical skin disinfection
US8119115B2 (en) 2006-02-09 2012-02-21 Gojo Industries, Inc. Antiviral method
AU2007238826B2 (en) * 2006-04-11 2012-09-13 Kpr U.S., Llc Wound dressings with anti-microbial and zinc-containing agents
US20070253909A1 (en) * 2006-05-01 2007-11-01 Medi-Flex, Inc. Aqueous Antiseptic Solution and Compatible Cationic Dye for Staining Skin
US20080108674A1 (en) * 2006-05-01 2008-05-08 Enturia, Inc. Cationic antiseptic and dye formulation
US20070254854A1 (en) * 2006-05-01 2007-11-01 Medi-Flex, Inc. Aqueous Antiseptic Solution and Compatible Anionic Dye for Staining Skin
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
JP5368300B2 (ja) 2006-06-08 2013-12-18 スリーエム イノベイティブ プロパティズ カンパニー ポリマービーズおよびポリマービーズの製造方法
US20080075793A1 (en) * 2006-09-21 2008-03-27 Dunshee Wayne K Antiviral compositions and methods of use
AU2007317622B2 (en) 2006-10-27 2010-12-16 3M Innovative Properties Company Antimicrobial compositions
DE102006051891A1 (de) 2006-10-31 2008-05-08 Schülke & Mayr GmbH Antimikrobiell wirksame Zusammensetzung mit einem Gehalt an Bispyridiniumalkan
JP4884180B2 (ja) * 2006-11-21 2012-02-29 東京エレクトロン株式会社 基板処理装置および基板処理方法
US20110097372A1 (en) * 2009-10-26 2011-04-28 Rucinski Paul J Devices, methods, and compositions for controlling infections
US8088095B2 (en) * 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
KR101461842B1 (ko) * 2007-02-08 2014-11-13 메드트로닉 좀드 인코퍼레이티드 의료용 용매화 시스템 및 실런트
US7939578B2 (en) * 2007-02-23 2011-05-10 3M Innovative Properties Company Polymeric fibers and methods of making
EP1982696B1 (de) * 2007-04-19 2010-05-19 Dr. August Wolff GmbH & Co. KG Arzneimittel Gel zur Behandlung von Wunden
US8747872B2 (en) * 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US8513322B2 (en) * 2007-05-31 2013-08-20 3M Innovative Properties Company Polymeric beads and methods of making polymeric beads
BRPI0820704A2 (pt) * 2007-12-12 2015-06-16 3M Innovative Proferties Company Métodos de fabricação de materiais poliméricos moldados
CA2709289A1 (en) 2007-12-12 2009-06-18 3M Innovative Properties Company Hydrophilic gel materials and methods of making
EP2234570A1 (en) * 2007-12-31 2010-10-06 3M Innovative Properties Company Medical dressing with edge port and methods of use
EP2625957A1 (en) * 2007-12-31 2013-08-14 3M Innovative Properties Company Antimicrobial compositions
BRPI0905679A2 (pt) * 2008-01-08 2015-07-07 Quick Med Technologies Inc Método para fabricar e desinfetar um substrato e composição para conferir atividade antimicrobiana durável em um substrato
JP2011516167A (ja) * 2008-04-04 2011-05-26 スリーエム イノベイティブ プロパティズ カンパニー マイクロポンプを有する創傷ドレッシング
US8784790B2 (en) 2008-06-12 2014-07-22 Medtronic Xomed, Inc. Method for treating chronic wounds with an extracellular polymeric substance solvating system
EP2361084B1 (en) * 2008-07-07 2017-03-01 Trutek Corp. Electrostatically charged multi-acting nasal application, product, and method
BRPI0910366A2 (pt) * 2008-07-14 2015-10-13 3M Innovative Properties Co método para preparo de uma solução para limpeza, embalagem de concentrado para limpeza em hidrogel e método para o preparo de uma microesfera de hidrogel
EP2349209A2 (en) 2008-09-26 2011-08-03 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
US20100086576A1 (en) * 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
US10322954B2 (en) 2008-11-20 2019-06-18 Hydro Air Global, Llc Antimicrobial device and materials for fluid treatment
US20100135949A1 (en) * 2008-12-01 2010-06-03 Becton, Dickinson And Company Antimicrobial compositions
US10314935B2 (en) 2009-01-07 2019-06-11 Entrotech Life Sciences, Inc. Chlorhexidine-containing antimicrobial laminates
US8597668B2 (en) * 2009-02-09 2013-12-03 L'oreal Clear carrier compositions for lipophilic compounds, and method of treating keratinous substrates using such compositions
US20100202995A1 (en) * 2009-02-09 2010-08-12 L'oreal Clear carrier compositions for lipophilic compounds, and method of treating keratinous substrates using such compositions
US8637489B2 (en) * 2009-02-09 2014-01-28 L'oreal Clear carrier compositions for lipophilic compounds, and method of treating keratinous substrates using such compositions
US20100202988A1 (en) * 2009-02-09 2010-08-12 L'oreal Clear carrier compositions containing an alkoxylated monoacid and an alkyl monoamine and method of treating keratinous substrates using such compositions
ES2846854T3 (es) * 2009-02-11 2021-07-29 Univ Ramot Composiciones antisépticas que comprenden iones de plata y mentol y usos de las mismas
JP2012526142A (ja) * 2009-05-08 2012-10-25 スリーエム イノベイティブ プロパティズ カンパニー 口腔ケア方法及びキット
CN102438601A (zh) * 2009-05-16 2012-05-02 特鲁特克公司 带静电荷的多功能鼻应用、产品和方法
EP3050545B1 (en) 2009-06-16 2019-07-24 3M Innovative Properties Company Conformable medical dressing with self supporting substrate
WO2011035158A2 (en) * 2009-09-17 2011-03-24 Guthery B Eugene Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria
WO2011047118A1 (en) 2009-10-14 2011-04-21 Water Visions International, Inc. Fibrous antimicrobial materials, structures, and barrier applications
JP2013508457A (ja) * 2009-10-26 2013-03-07 イノベーション テクノロジーズ インコーポレーティッド 感染を制御するための装置、方法、および組成物
DE102010010174A1 (de) * 2010-03-03 2011-09-08 Bode Chemie Gmbh Antimikrobielle Öl-in-Wasser-Emulsion enthaltend quaternäre Ammoniumverbindungen
DE102010013081A1 (de) * 2010-03-26 2011-09-29 B. Braun Melsungen Ag Antimikrobielle Öl in Wasser Emulsion
DE102010013274A1 (de) * 2010-03-29 2011-11-17 Beiersdorf Ag Mikrobiologisch stabile anwendungsfreundliche Zubereitungen
CN101812383B (zh) * 2010-05-20 2012-02-22 北京绿伞化学股份有限公司 一种消毒洗涤剂及其制备方法
CN101869537B (zh) * 2010-06-29 2012-02-08 大连欧派科技有限公司 一种女士洁阴湿巾
CN102970995A (zh) 2010-06-29 2013-03-13 3M创新有限公司 稳定的抗菌组合物及方法
US20130165880A1 (en) 2010-09-17 2013-06-27 David T. Amos Antimicrobial disposable absorbent articles
EP2632613B1 (en) 2010-10-28 2017-08-30 3M Innovative Properties Company Engineered surfaces for reducing bacterial adhesion
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
US10653133B2 (en) 2011-05-10 2020-05-19 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
WO2013003373A1 (en) 2011-06-27 2013-01-03 3M Innovative Properties Company Microstructured surfaces for reducing bacterial adhesion
FR2978664B1 (fr) 2011-08-04 2014-01-10 Petcare Innovation Composition antiseptique
WO2013043608A1 (en) * 2011-09-20 2013-03-28 Bio-Rad Laboratories, Inc. Removal of virucidal agents from biomolecule preparations
EP2779998A1 (en) 2011-11-16 2014-09-24 3M Innovative Properties Company Polymeric colorant compositions and methods of use
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US8829053B2 (en) 2011-12-07 2014-09-09 Rochal Industries Llp Biocidal compositions and methods of using the same
WO2013101884A1 (en) 2011-12-29 2013-07-04 3M Innovative Properties Company Filled incise drape
US20130255061A1 (en) * 2012-04-03 2013-10-03 Becton, Dickinson And Company Systems and methods for applying a novel antimicrobial coating material to a medical device
US9352119B2 (en) 2012-05-15 2016-05-31 Becton, Dickinson And Company Blood control IV catheter with antimicrobial properties
US9579486B2 (en) 2012-08-22 2017-02-28 Becton, Dickinson And Company Blood control IV catheter with antimicrobial properties
AU2013309002B2 (en) * 2012-08-28 2016-05-26 3M Innovative Properties Company Chlorhexidine gluconate compositions, resin systems and articles
DE102012215511A1 (de) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
JP5872430B2 (ja) * 2012-09-20 2016-03-01 日本電子照射サービス株式会社 グルコン酸クロルヘキシジン製剤、消毒用キット及び滅菌方法
US10342628B2 (en) 2012-09-21 2019-07-09 3M Innovative Properties Company Incision protection
EP2935688A2 (en) 2012-12-20 2015-10-28 ConvaTec Technologies Inc. Processing of chemically modified cellulosic fibres
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
CN103081940B (zh) * 2013-02-05 2014-06-18 河南科技学院 一种复方醋酸氯己定微乳消毒剂及其制备方法
US9695323B2 (en) 2013-02-13 2017-07-04 Becton, Dickinson And Company UV curable solventless antimicrobial compositions
US9750928B2 (en) 2013-02-13 2017-09-05 Becton, Dickinson And Company Blood control IV catheter with stationary septum activator
CN105051123A (zh) * 2013-02-21 2015-11-11 科林斯波特公司 对经常触摸的表面的处理用于改善卫生
GB201308770D0 (en) 2013-05-15 2013-06-26 Convatec Technologies Inc Wound Dressing Comprising an Antimicrobial Composition
CA2912766C (en) 2013-05-21 2021-09-07 3M Innovative Properties Company Nanostructured spore carrier
US10682830B2 (en) 2013-06-06 2020-06-16 3M Innovative Properties Company Successively peelable coextruded polymer film with embedded antimicrobial layer(s)
EP3013146B1 (en) 2013-06-28 2020-11-25 3M Innovative Properties Company Wipe with a guanidinyl-containing polymer
WO2015013093A1 (en) 2013-07-23 2015-01-29 3M Innovative Properties Company Adjustable wound dressing
US11684069B2 (en) 2013-09-13 2023-06-27 3M Innovative Properties Company Cationic antiseptic compositions
GB201405660D0 (en) * 2014-03-28 2014-05-14 Gama Healthcare Ltd A liquid disinfecting composition
US11039615B2 (en) 2014-04-18 2021-06-22 Entrotech Life Sciences, Inc. Methods of processing chlorhexidine-containing polymerizable compositions and antimicrobial articles formed thereby
US9789279B2 (en) 2014-04-23 2017-10-17 Becton, Dickinson And Company Antimicrobial obturator for use with vascular access devices
US9675793B2 (en) 2014-04-23 2017-06-13 Becton, Dickinson And Company Catheter tubing with extraluminal antimicrobial coating
US10376686B2 (en) 2014-04-23 2019-08-13 Becton, Dickinson And Company Antimicrobial caps for medical connectors
US9970303B2 (en) 2014-05-13 2018-05-15 Entrotech, Inc. Erosion protection sleeve
US20160354307A1 (en) * 2014-05-19 2016-12-08 Carl Hilliard Antimicrobial composition and methods of use
US10232088B2 (en) 2014-07-08 2019-03-19 Becton, Dickinson And Company Antimicrobial coating forming kink resistant feature on a vascular access device
US9848604B2 (en) * 2014-07-11 2017-12-26 Medtronic Xomed, Inc. Antimicrobial wash
WO2016048304A1 (en) * 2014-09-24 2016-03-31 Colgate-Palmolive Company Bioavailability of metal ions
EP3233036B1 (en) 2014-12-15 2023-01-25 3M Innovative Properties Company Kits for removing calculus
EP3253370A4 (en) * 2015-02-05 2018-08-01 Marc Selner Ionic nanovesicle suspension and biocide prepared therefrom
US10813357B1 (en) 2015-05-26 2020-10-27 Gojo Industries, Inc. Compositions and methods with efficacy against spores and other organisms
US12433856B2 (en) 2015-06-19 2025-10-07 Global Health Solutions Llc Petrolatum-based compositions and methods of treatment for onychomycosis
US12290599B2 (en) 2015-06-19 2025-05-06 Global Health Solutions Llc Oil-based wound care compositions and methods
CN108136026A (zh) * 2015-06-19 2018-06-08 全球健康方案有限责任公司 包含阳离子杀生物剂的基于凡士林的组合物
US11110071B2 (en) 2015-06-19 2021-09-07 Global Health Solutions Llc Petrolatum-based PHMB compositions and methods of treatment for onychomycosis
EP3725153B1 (en) 2015-07-27 2024-09-04 Kimberly-Clark Worldwide, Inc. Residual disinfectant composition
CN105106029A (zh) * 2015-09-10 2015-12-02 高密市丽美化妆品有限公司 新型化妆品防腐剂
US20170100383A1 (en) * 2015-10-13 2017-04-13 Practical Solution, Inc. Topical formulations for preventing skin infection
US10493244B2 (en) 2015-10-28 2019-12-03 Becton, Dickinson And Company Extension tubing strain relief
US10188598B1 (en) 2015-11-25 2019-01-29 Sage Products, Llc Sterilized chlorhexidine article and method of sterilizing a chlorhexidine article
SE1650162A1 (en) * 2016-02-09 2017-08-10 Karladani Abbas Antimicrobial and cleansing composition comprising a polymeric biguanide, EDTA, and surfactants.
CN109414392B (zh) 2016-06-22 2022-07-08 3M创新有限公司 移除结石的方法和试剂盒
CN106214926A (zh) * 2016-07-29 2016-12-14 腾科宝迪（厦门）生物科技有限公司 一种鼻喷雾剂及其制备方法
AU2017347537B2 (en) 2016-10-20 2020-07-09 3M Innovative Properties Company Methods and kits for removing calculus using a non-enzymatic, hydrogen peroxide decomposition catalyst
CN109843249A (zh) 2016-10-20 2019-06-04 3M创新有限公司 用于使用金属离子和碳酸氢根移除结石的方法和试剂盒
CN109923151B (zh) 2016-11-03 2021-08-20 3M创新有限公司 有机硅共聚物、制备方法和制品
CN106421217B (zh) * 2016-11-14 2017-12-01 广东洛斯特制药有限公司 一种苯扎氯铵的溶液及其制备方法
WO2018217761A1 (en) * 2017-05-23 2018-11-29 Hitchcock Wiley William Antimicrobial composition
CN110769931B (zh) * 2017-06-17 2024-09-17 株式会社Acenet 自由基产生催化剂、自由基的制造方法、氧化反应产物的制造方法、药剂和农畜产用药剂
JPWO2019026992A1 (ja) * 2017-08-03 2020-06-18 参天製薬株式会社 クロルヘキシジンを含有する医薬組成物
US11744248B2 (en) * 2017-08-20 2023-09-05 Enviro Specialty Chemicals Inc. Disinfectant composition for control of clostridium difficile spore
JP7337778B2 (ja) * 2017-08-30 2023-09-04 ノビオ リミテッド 抗微生物粒子を含む組成物および医療機器
WO2019060697A1 (en) 2017-09-22 2019-03-28 Becton, Dickinson And Company 4% TRISODIC CITRATE SOLUTION FOR USE AS A CATHETER LOCK SOLUTION
TWI884133B (zh) * 2018-04-06 2025-05-21 香港商醫鎧科技（香港）有限公司 用於醫療保健環境的耐用抗菌處理之紡織品及其製備方法
CN112105265A (zh) * 2018-04-09 2020-12-18 罗地亚经营管理公司 用于持久消毒的组合物和方法
GB201810925D0 (en) * 2018-07-03 2018-08-15 Blueberry Therapeutics Ltd Compositions and methods of treatment
CN108904859A (zh) * 2018-07-23 2018-11-30 衢州玛济克医疗科技有限公司 一种痔疮医用敷料及其生产方法
CN108837175A (zh) * 2018-07-23 2018-11-20 衢州玛济克医疗科技有限公司 一种清创医用敷料及其生产方法
EP3866601A4 (en) 2018-10-18 2022-08-17 Topikos Pharmaceuticals, Inc. ORGANOSILANES TO TREAT AN INFECTION
DE102018220631A1 (de) * 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
CN109298101A (zh) * 2018-12-03 2019-02-01 山东省食品药品检验研究院 一种小麦粉及其制品中间苯二酚的高效液相色谱测定方法
CN111265473A (zh) * 2018-12-04 2020-06-12 南京从一医药科技有限公司 一种具有阻隔异物和杀菌作用的双功能鼻保护凝胶
US12295923B2 (en) 2018-12-27 2025-05-13 Solventum Intellectual Properties Company Antimicrobial compositions with 1,2-alkanediols
CA3130138A1 (en) * 2019-02-27 2020-09-03 Oticara, Inc. Method for treating nasal, sinonasal, and nasopharyngeal tissue infection and/or inflammation
CN113645946A (zh) 2019-04-01 2021-11-12 3M创新有限公司 抗微生物组合物
US12390487B2 (en) 2019-04-05 2025-08-19 Solventum Intellectual Properties Company Antiseptic skin prep composition
WO2021014193A1 (en) * 2019-07-22 2021-01-28 Gojo Industries, Inc. Antimicrobial compositions
CA3147351A1 (en) 2019-07-23 2021-01-28 Unilever Global Ip Limited A water-in-oil emulsion composition for enhanced delivery of water soluble skin benefit agents
EP4017654A1 (en) 2019-08-20 2022-06-29 3M Innovative Properties Company Microstructured surface with increased microorganism removal when cleaned, articles and methods
US11766822B2 (en) 2019-08-20 2023-09-26 3M Innovative Properties Company Microstructured surface with increased microorganism removal when cleaned, articles and methods
US12434427B2 (en) 2019-08-20 2025-10-07 Solventum Intellectual Properties Company Microstructured surface with increased microorganism removal when cleaned, articles and methods
EP4017401A1 (en) 2019-08-20 2022-06-29 3M Innovative Properties Company Medical articles with microstructured surface having increased microorganism removal when cleaned and methods thereof
CA3154947A1 (en) 2019-10-18 2021-04-23 Gary Allred Antimicrobial organosilanes
AU2020437820A1 (en) * 2019-12-03 2022-06-30 Massachusetts Institute Of Technology Body fluid resistant tissue adhesives
CN111213674B (zh) * 2019-12-06 2021-07-02 鲁东大学 一种具有抑菌活性的化合物及其制备方法和应用
GB201919234D0 (en) 2019-12-23 2020-02-05 Jvs Products Ltd Compositions
GB202006794D0 (en) * 2020-05-07 2020-06-24 Quin Global Uk Ltd Hand sanitising composition, apparatus and dispensing unit
US20230158557A1 (en) 2020-05-20 2023-05-25 3M Innovative Properties Company Medical Articles with Microstructured Surface
EP4163339A4 (en) * 2020-06-05 2024-06-19 Energyfront Inc. COATING FILM AND ARTICLES WITH THE COATING FILM FORMED ON THE SURFACE
WO2021260605A1 (en) * 2020-06-25 2021-12-30 Samad, Abdul Barrier films
CA3190534A1 (en) * 2020-08-31 2022-03-03 Salvacion Usa Inc. Antiviral composition and use of the same
WO2022122131A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprising lipophilic compounds and one or more (bio)-alkanediols
EP4259415A1 (en) 2020-12-11 2023-10-18 3M Innovative Properties Company Method of thermoforming film with structured surface and articles
JP2022092900A (ja) * 2020-12-11 2022-06-23 サンスター株式会社 口腔用組成物
CN112724770B (zh) * 2020-12-25 2022-03-29 广州慧谷化学有限公司 一种抗菌防霉亲水涂料
WO2022162528A1 (en) 2021-01-28 2022-08-04 3M Innovative Properties Company Microstructured surface with increased microorganism removal when cleaned, articles and methods
US20240108613A1 (en) * 2021-02-05 2024-04-04 Acp Laboratories Llc Topical composition for treating fungi forming on a user's body
US20240115476A1 (en) * 2021-02-08 2024-04-11 Rhodia Operations Compositions comprising a multi-tail surfactant and a cationic polymer and uses
WO2022180466A1 (en) 2021-02-23 2022-09-01 3M Innovative Properties Company Medical articles with microstructured surface having increased microorganism removal when cleaned and methods thereof
US12208150B2 (en) * 2021-05-20 2025-01-28 Shielded, Beauty, LLC Antimicrobial skincare composition
CN117677295A (zh) * 2021-07-23 2024-03-08 3M创新有限公司 奥替尼啶组合物及其使用方法
WO2023042072A1 (en) 2021-09-14 2023-03-23 3M Innovative Properties Company Articles including a microstructured curved surface and methods of making same
WO2023047205A1 (en) 2021-09-23 2023-03-30 3M Innovative Properties Company Methods of making smooth thermoformed articles
WO2023105372A1 (en) 2021-12-07 2023-06-15 3M Innovative Properties Company Microstructured surface and articles with lower visibilty of scratches and methods
KR102852787B1 (ko) * 2021-12-28 2025-08-28 단국대학교 천안캠퍼스 산학협력단 신규한 화합물을 포함하는 생리 식염수
CN116413230A (zh) * 2021-12-31 2023-07-11 江苏百赛飞生物科技有限公司 检测聚合物杀菌效果的方法
US20260070777A1 (en) 2022-08-31 2026-03-12 Solventum Intellectual Properties Company Articles including a microstructured curved surface, tooling articles, and methods
CN117402427A (zh) * 2023-11-10 2024-01-16 嘉丰工业科技（惠州）有限公司 防细菌聚合物材料及其制备方法和应用
CN117903479B (zh) * 2024-01-18 2025-08-01 中国化工集团曙光橡胶工业研究设计院有限公司 一种天然橡胶的防霉方法
WO2025238215A1 (de) 2024-05-16 2025-11-20 Colt Prüf Und Test Gmbh Verfahren zur herstellung eines alkoholfreien desinfektionsmittels
WO2026013408A1 (en) * 2024-07-11 2026-01-15 Convatec Limited Urinary catheters
CN119551789A (zh) * 2024-10-22 2025-03-04 邯郸派瑞电器有限公司 一种具有螯合功能的重金属沉淀剂及其制备方法与应用

Family Cites Families (154)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2818390A (en) * 1954-04-16 1957-12-31 Monsanto Chemicals Halogenated carbanilides
GB882742A (en) 1959-02-19 1961-11-22 Chesebrough Ponds Anhydrous germicidal compositions
SE385007B (sv) 1971-08-31 1976-05-31 Ciba Geigy Ag Tiadiazolderivat till anvendning som fungicida medel, som betmedel for utsede och som skydd for organiskt material mot angrepp av skadliga mikroorganismer
DE2242187A1 (de) 1971-08-31 1973-03-08 Ciba Geigy Ag Heterocyclische verbindungen
BE788151A (fr) 1971-08-31 1973-02-28 Ciba Geigy Thiadiazoles pouvant servir de fongicides pour le traitement des semences et des terres et de substances actives pour medicaments
US4010252A (en) * 1974-12-19 1977-03-01 Colgate-Palmolive Company Antimicrobial compositions
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
IL52045A (en) * 1976-08-25 1979-12-30 Mundipharma Ag Sprayable germicidal foam compositions
JPS5366415A (en) 1976-11-19 1978-06-13 Nobuo Nishiyama Ointment for activaing and regenerating damaged skin cell
US4148917A (en) 1977-06-13 1979-04-10 The Procter & Gamble Company Dermatological compositions
WO1981002977A1 (en) * 1980-04-25 1981-10-29 Orthana Kemisk Fab As Sterilized,preserved,stable mucine-containing solutions and sterilization method
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
CA1199273A (en) * 1982-07-15 1986-01-14 Ctibor Schindlery Anti-inflammatory composition
JPS6044539A (ja) 1983-08-22 1985-03-09 Kawaguchi Kagaku Kogyo Kk ゴム加工助剤の顆粒状製品の製造法
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
US4983595A (en) * 1986-05-22 1991-01-08 Syntex (U.S.A.) Inc. Aqueous steroid formulations for nasal administration
JPS63130541A (ja) 1986-11-18 1988-06-02 Sunstar Inc 抗菌性組成物
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US4894220A (en) * 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5344641A (en) * 1987-01-30 1994-09-06 Colgate-Palmolive Co. Antibacterial antiplaque oral composition
JPH0625090B2 (ja) * 1987-02-12 1994-04-06 花王株式会社 毛髪化粧料
AU596272B2 (en) * 1987-02-25 1990-04-26 Trustees Of Columbia University In The City Of New York, The Method of inhibiting the transmission of aids virus
US4931282A (en) * 1987-11-25 1990-06-05 Minnesota Mining And Manufacturing Company Pressure-sensitive medical sealant
US5225473A (en) * 1987-11-25 1993-07-06 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesives
US5719197A (en) 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
JPH02140167A (ja) 1988-11-22 1990-05-29 Saraya Kk 手指消毒用組成物
CA1316623C (en) * 1989-04-06 1993-04-20 Pavel Stovicek Biocidal surface coating and casting compositions based on quarternary ammonium salts of nalkyl x,x bis (4,4' hydroxyphenyl) and quarternary salts of polyglycols as backbones of resins
US5318955A (en) * 1989-04-07 1994-06-07 Henkel Kommanditgesellschaft Auf Aktien Use of selected ethers of monofunctional alcohols in drilling fluids
US5076859A (en) 1989-12-26 1991-12-31 Aluminum Company Of America Heat treatment of aluminum-lithium alloys
US5314694A (en) * 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
CA2108008C (en) * 1991-04-10 1999-05-04 Christopher C. Capelli Antimicrobial compositions useful for medical applications
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
EP0537774B1 (en) * 1991-10-18 1998-01-07 Kuraray Co., Ltd. Antimicrobial polymerizable composition, the polymer and article obtained from the same
US5336432A (en) 1992-01-24 1994-08-09 John Petchul Composition for microemulsion gel having bleaching and antiseptic properties
US6197346B1 (en) 1992-04-24 2001-03-06 Brown Universtiy Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
JPH06166623A (ja) * 1992-09-25 1994-06-14 Toyama Chem Co Ltd 抗菌性組成物
US5429819A (en) * 1992-10-14 1995-07-04 Matsushita Electric Industrial Co., Ltd. Antiviral composition
DE4302812A1 (de) 1993-02-02 1994-08-04 Bode Chemie Gmbh & Co Peroxidentwickelnde Desinfektionsmittel oder -antiseptika
EP0684834A4 (en) 1993-02-17 1996-09-25 Smithkline Beecham Corp MICROEMULSIONS CONTAINING THERAPEUTIC PEPTIDES.
DE59406509D1 (de) 1993-05-26 1998-08-27 Fresenius Ag Antiinfektivum
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US6238682B1 (en) * 1993-12-13 2001-05-29 The Procter & Gamble Company Anhydrous skin lotions having antimicrobial components for application to tissue paper products which mitigate the potential for skin irritation
US5817325A (en) * 1996-10-28 1998-10-06 Biopolymerix, Inc. Contact-killing antimicrobial devices
EP0748203A1 (en) 1994-03-11 1996-12-18 The Procter & Gamble Company LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES
MX9604411A (es) * 1994-03-28 1997-12-31 Univ Columbia Composicion para inactivar irritantes en fluidos.
JP2677775B2 (ja) * 1994-04-14 1997-11-17 株式会社東芝 再生装置
TW438601B (en) 1994-05-18 2001-06-07 Janssen Pharmaceutica Nv New mucoadhesive emulsion compositions and a process for the preparation thereof
US5547677A (en) * 1994-05-20 1996-08-20 Novavax, Inc. Antimicrobial oil-in-water emulsions
US6071866A (en) * 1994-06-01 2000-06-06 Lever Brothers Company, Division Of Conopco, Inc. Mild antimicrobial liquid cleansing formulations comprising hydroxy acid buffering compound or compounds as potentiator of antimicrobial effectiveness
JPH0815132A (ja) 1994-07-05 1996-01-19 Nippon Laser Denshi Kk 表面プラズモン発生用光線反射器
JP3515821B2 (ja) * 1994-10-21 2004-04-05 株式会社資生堂 消毒用組成物
JP3968131B2 (ja) 1994-11-28 2007-08-29 サンスター株式会社 抗菌製剤
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
GB9512290D0 (en) 1995-06-16 1995-08-16 Moorfields Eye Hospital Uses of polyhexanide
EP1374847A1 (en) * 1995-06-22 2004-01-02 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US6123933A (en) * 1995-07-19 2000-09-26 Mitsubishi Chemical Corporation Hair cosmetic compositions
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
JPH09124459A (ja) * 1995-10-27 1997-05-13 Kao Corp 肛門周辺清拭用組成物
US6008173A (en) 1995-11-03 1999-12-28 Colgate-Palmolive Co. Bar composition comprising petrolatum
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
GB9616208D0 (en) * 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
AU1530697A (en) 1996-09-06 1998-03-26 Minnesota Mining And Manufacturing Company Antimicrobial compositions
JP4346685B2 (ja) * 1996-10-21 2009-10-21 ユーロビタ アクティーゼルスカブ パルテニウム・インテグリフォリウム又はその部分若しくはそのエキス又はその成分を含有する医薬組成物、かかる植物材料の医薬製造のための使用、及びパルテニウム・インテグリフォリウムのエキスの製造方法
US6338855B1 (en) * 1996-10-25 2002-01-15 The Procter & Gamble Company Cleansing articles for skin and/or hair which also deposit skin care actives
EP0869216A1 (en) 1997-04-02 1998-10-07 Reckitt & Colman Inc. Flexible hydrophilic articles having a durable antimicrobial effect
US6287577B1 (en) * 1997-11-12 2001-09-11 The Procter & Gamble Company Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6210695B1 (en) * 1997-06-04 2001-04-03 The Procter & Gamble Company Leave-on antimicrobial compositions
DE19733684A1 (de) * 1997-08-04 1999-02-11 Henkel Kgaa Konservierungsmittelsystem für Körperpflegemittel
US20020052390A1 (en) * 1997-10-22 2002-05-02 Jens Ponikau Methods and materials for treating and preventing inflammation of mucosal tissue
IL122084A (en) 1997-10-31 1999-09-22 Lurident Ltd Formulation for personal care with mucoadhesive properties
US6171611B1 (en) * 1997-11-12 2001-01-09 Dante J. Picciano Iodine-containing nasal moisturizing saline and mouthwash solutions
US5897872A (en) * 1997-11-12 1999-04-27 Picciano; Dante J. Iodine-containing nasal moisturizing saline solution
US6022551A (en) * 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US6248343B1 (en) * 1998-01-20 2001-06-19 Ethicon, Inc. Therapeutic antimicrobial compositions
US20020022660A1 (en) 1998-01-20 2002-02-21 Hanuman B. Jampani Deep penetrating antimicrobial compositions
US20010053775A1 (en) * 1998-01-30 2001-12-20 Matthias Seidel Nasal solutions
US6054143A (en) * 1998-03-24 2000-04-25 Jones; Alonzo H. Xylitol delivery
WO1999051192A2 (en) 1998-04-03 1999-10-14 Colgate-Palmolive Company Low residue cosmetic composition
GB9810803D0 (en) 1998-05-21 1998-07-22 Boots Co Plc Topical compositions
JP3883739B2 (ja) * 1998-05-22 2007-02-21 株式会社メニコン コンタクトレンズ用殺菌液
IL139231A0 (en) 1998-05-27 2001-11-25 Euro Celtique Sa Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
JP3592080B2 (ja) 1998-06-08 2004-11-24 吉田製薬株式会社 粘稠な速乾性殺菌消毒剤
CN1306393A (zh) 1998-06-22 2001-08-01 宝洁公司 经处理的擦巾制品
GB2338649A (en) 1998-06-25 1999-12-29 Brian Francis Hawtin Nasal antiseptic compositions
US20020119579A1 (en) 1998-07-14 2002-08-29 Peter Wagner Arrays devices and methods of use thereof
US6071541A (en) * 1998-07-31 2000-06-06 Murad; Howard Pharmaceutical compositions and methods for managing skin conditions
ATE266429T1 (de) * 1998-08-14 2004-05-15 Coloplast As Stabilisierte zusammensetzungen mit antibakterieller wirksamkeit
US20030147925A1 (en) * 1998-09-11 2003-08-07 Samuel P. Sawan Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same
WO2000015036A1 (en) 1998-09-11 2000-03-23 Surfacine Development Company, Llc Topical dermal antimicrobial compositions
NZ512267A (en) * 1998-11-09 2003-11-28 Ira Jay Newman Ionic silver complex
US20040091428A1 (en) 1999-01-04 2004-05-13 Barry M. Libin Method of preventing and treating mucosal and dermal conditions
US6534075B1 (en) * 1999-03-26 2003-03-18 Ecolab Inc. Antimicrobial and antiviral compositions and treatments for food surfaces
US6635676B2 (en) 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US6559189B2 (en) * 1999-04-28 2003-05-06 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US6187327B1 (en) * 1999-05-19 2001-02-13 Kevin Stack Antimicrobial sanitizing lotion with skin protection properties
US6440405B1 (en) * 1999-06-07 2002-08-27 University Of Delaware Quaternary ammonium functionalized dendrimers and methods of use therefor
US6187332B1 (en) * 1999-06-14 2001-02-13 Wisconsin Alumni Research Foundation Acidic buffered nasal spray
US6309633B1 (en) * 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
US6723714B2 (en) * 1999-07-06 2004-04-20 Blansett Pharmacal Co., Inc. Aqueous solvent for corticosteroids
US6313246B1 (en) * 1999-07-07 2001-11-06 Nalco Chemical Company High molecular weight zwitterionic polymers
DE50012930D1 (de) 1999-07-20 2006-07-20 Beiersdorf Ag Emulgatorfreie feindisperse systeme vom typ wasser-in-öl
BR0012674A (pt) 1999-07-22 2002-09-17 Aventis Pharma Inc Formulações farmacêuticas preservadas
DE60012026T2 (de) * 1999-08-26 2004-12-30 Ganeden Biotech, Inc., San Diego Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
US6211243B1 (en) * 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
AU8029700A (en) 1999-10-19 2001-04-30 Procter & Gamble Company, The Antimicrobial compositions comprising pyroglutamic acid and metal salts
DE60043451D1 (de) * 1999-11-24 2010-01-14 3M Innovative Properties Co Desinfektionsmittel für früchte, gemüse und samen
NZ501386A (en) 1999-11-29 2002-10-25 Nz Inst For Crop & Food Res Collagen from fish skin
US6315989B1 (en) * 1999-12-22 2001-11-13 Revlon Consumer Products Corporation Water in oil microemulsion peroxide compositions for use in coloring hair and related methods
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US6224898B1 (en) * 2000-03-23 2001-05-01 The United States Of America As Represented By The Secretary Of The Army Antimicrobial dendrimer nanocomposites and a method of treating wounds
US6422778B2 (en) * 2000-04-03 2002-07-23 3M Innovative Properties Company Surgical prep solution applicator system and methods
US6579906B2 (en) * 2000-06-09 2003-06-17 University Of Delaware Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials
AR031108A1 (es) 2000-06-19 2003-09-10 Colgate Palmolive Co Un metodo para mejorar la actividad de una sal de aluminio o de aluminio/circonio que contiene especies de aluminio pequenas y grandes, las sales asi obtenidas y los productos antitranspirantes y/o desodorantes preparados con dichas sales mejoradas
JP4597318B2 (ja) * 2000-06-21 2010-12-15 ピジョン株式会社 防腐抗菌性が改善された水性組成物
JP2002012118A (ja) 2000-06-30 2002-01-15 Mitsuboshi Belting Ltd エアバッグドア一体型インストルメントパネル及びその製造方法
US20020031556A1 (en) * 2000-07-21 2002-03-14 Lindahl Ake R. Stabilized hydrogen peroxide composition and method of making a stabilized hydrogen peroxide composition
FR2812192B1 (fr) 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
US6500861B1 (en) * 2000-08-23 2002-12-31 Michael D. Wider Antimicrobial composition and methods of use in the treatment of disease
FR2813189B1 (fr) * 2000-08-31 2003-02-28 Oreal Creme cosmetique moussante pour le traitement des peaux grasses
WO2002028331A1 (en) * 2000-10-05 2002-04-11 Seacoast Technologies, Inc. Expandable device for thermal therapy including spiral element
JP5009468B2 (ja) * 2000-10-18 2012-08-22 千寿製薬株式会社 局所用水性液剤
US6383505B1 (en) * 2000-11-09 2002-05-07 Steris Inc Fast-acting antimicrobial lotion with enhanced efficacy
US6462025B2 (en) * 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US7923469B2 (en) * 2001-04-30 2011-04-12 Allergen, Inc. Compositions including vitamin-based surfactants and methods for using same
WO2002094179A2 (en) * 2001-05-23 2002-11-28 J.B. Chemicals & Pharmaceuticals Ltd. Novel topical microbicidal compositions
AU2002367976B2 (en) * 2001-06-05 2007-06-21 The Regents Of The University Of Michigan Nanoemulsion vaccines
US20030103867A1 (en) 2001-06-19 2003-06-05 Welch Allyn, Inc. Compact diagnostic testing device
US6833478B2 (en) 2001-07-13 2004-12-21 Sri International N,N-dinitramide salts as solubilizing agents for biologically active agents
JP2004537401A (ja) * 2001-08-08 2004-12-16 ブラウン ユニバーシティ リサーチ ファウンデーション 疎水性薬物の微粉砕方法
US20030059378A1 (en) 2001-09-06 2003-03-27 Libin Barry M. Method of preventing mucositis
US6494856B1 (en) * 2001-09-12 2002-12-17 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Swab deliverable actives
US7030203B2 (en) * 2001-09-28 2006-04-18 3M Innovative Properties Company Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
US6951642B2 (en) * 2001-09-28 2005-10-04 3M Innovative Properties Company Water-in-oil emulsions with anionic groups, compositions, and methods
US20030091540A1 (en) 2001-10-16 2003-05-15 Nawaz Ahmad Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
JP2003221320A (ja) * 2002-01-29 2003-08-05 Lion Corp 口腔用組成物
US20030158128A1 (en) 2002-02-12 2003-08-21 Ford John P. Treatment, composition and method using uracil against side-effects of chemotherapy
EP1512408A4 (en) 2002-06-13 2008-01-23 Hououdou Co Ltd ANTIBACTERIAL AGENT AND ANTIBACTERIAL COMPOSITION
AU2003296937A1 (en) 2002-12-10 2004-06-30 Biosynexus Incorporated Topical anti-infective formulations
US20040120916A1 (en) * 2002-12-23 2004-06-24 Advanced Medical Optics, Inc. Contact lens care compositions, methods of use and preparation which protect ocular tissue membrane integrity
US20040180093A1 (en) * 2003-03-12 2004-09-16 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US20040208908A1 (en) * 2003-04-16 2004-10-21 The Trustees Of Columbia University In The City Of New York Antimicrobial medical articles containing a synergistic combination of anti-infective compounds and octoxyglycerin
BRPI0414193A (pt) 2003-09-09 2006-10-31 3M Innovative Properties Co composição antimicrobiana, kit antimicrobiano e métodos de usar a composição e de aplicar uma composição antimicrobiana a um substrato
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US20050123621A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Silver coatings and methods of manufacture
US7745509B2 (en) * 2003-12-05 2010-06-29 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US20050123590A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Wound dressings and methods
US20060034899A1 (en) * 2004-08-12 2006-02-16 Ylitalo Caroline M Biologically-active adhesive articles and methods of manufacture
US20060035039A1 (en) * 2004-08-12 2006-02-16 3M Innovative Properties Company Silver-releasing articles and methods of manufacture
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
EP2497460A1 (en) 2005-03-10 2012-09-12 3M Innovative Properties Co. Methods of reducing microbial contamination
KR20070113281A (ko) 2005-03-10 2007-11-28 쓰리엠 이노베이티브 프로퍼티즈 컴파니 항미생물성 조성물 및 방법

Also Published As

Publication number Publication date
CA2579243A1 (en) 2006-03-16
JP5154933B2 (ja) 2013-02-27
AU2005282377A1 (en) 2006-03-16
JP2013040177A (ja) 2013-02-28
AU2005282377B2 (en) 2011-07-28
WO2006029255A2 (en) 2006-03-16
WO2006029255A3 (en) 2009-04-16
US20150231248A1 (en) 2015-08-20
US9028852B2 (en) 2015-05-12
US20060051385A1 (en) 2006-03-09
JP2018008969A (ja) 2018-01-18
EP1786264A4 (en) 2012-10-17
CN101437394A (zh) 2009-05-20
EP1786264A2 (en) 2007-05-23
MX2007002725A (es) 2007-05-16
EP1786264B1 (en) 2017-11-22
JP2015129149A (ja) 2015-07-16
CA2969582A1 (en) 2006-03-16
CN101437394B (zh) 2012-10-10
EP3275437A1 (en) 2018-01-31
TW200616609A (en) 2006-06-01
US10016501B2 (en) 2018-07-10
JP2008512389A (ja) 2008-04-24
MX343725B (es) 2016-11-18
US20160235848A1 (en) 2016-08-18
KR20070102479A (ko) 2007-10-18
CA2579243C (en) 2018-09-18

Similar Documents

Publication Publication Date Title
US10827749B2 (en) Compositions and methods with efficacy against spores and other organisms
Percival et al. Antiseptics for treating infected wounds: efficacy on biofilms and effect of pH
KR101057609B1 (ko) Ｎ,ｎ-디할로겐화 아미노산 및 유도체
TW200616609A (en) Cationic antiseptic compositions and methods of use
US4814334A (en) Composition with high bactericidal power containing a biguanide and a pyrimidine
CN101310726A (zh) 含醇的聚六亚甲基胍碘消毒剂及其制备方法
BR0210791A (pt) Composição tendo atividade bacteristática e bactericida contra esporos bacterianos e células vegetativas e processo para tratamento de alimentos utilizando a mesma
US11553714B2 (en) Anti-microbial compositions comprising quaternary organosilane compounds
CN114269159A (zh) 用于防止微生物生长的组合物、试剂盒、方法和用途
SE1650162A1 (en) Antimicrobial and cleansing composition comprising a polymeric biguanide, EDTA, and surfactants.
US20180220647A1 (en) Compositions and methods having improved efficacy against spores and other organisms
ES2128404T3 (es) Derivados de dibekacina y derivados de arbekacina activos contra bacterias resistentes, y la produccion de los mismos.
CN111617063B (zh) 一种免洗消毒液
EP2251003A2 (en) Ophthalmic Compositions for the Re-epithelialization, Healing and Disinfection of the Eye Tissues
US12156524B2 (en) Disinfectants with iodine and copper complexes
TR200101433T2 (tr) Enfeksiyonların tedavisinde fosfonoformik asit türevlerinin kullanımı.
KR102267156B1 (ko) 살균 및 소독용 조성물 및 그 제조방법
EP1635802B1 (en) Method for inhibiting the growth of antibiotic-resistant bacteria by using pentane-1,5-diol
CN113521042A (zh) 一种儿童专用无醇免洗病毒灭活消毒剂及其制备方法
US20230389553A1 (en) Disinfectants with iodine and copper complexes for biofilm eradication and prevention
US20260124014A1 (en) Incise drape and manufacturing method thereof
WO2025006425A2 (en) Disinfectants with iodine and copper complexes for biofilm eradication and prevention
WO2016077274A1 (en) Buffered hydroalcoholic povidone iodine composition and method
CN113952291A (zh) 一种防病毒病菌侵入的无毒护手凝胶及其制备方法
WO2021214361A1 (es) Antiséptico de acción prolongada para el lavado higiénico por fricción y lavado pre-quirúrgico de manos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL